Transgene Biotek Limited submitted additional details to BSE Limited in response to observations raised regarding the company's corporate announcement filed on 29-October-2026 at 10:27 AM concerning the resignation of their statutory auditors. The submission was made under Regulation 30 of SEBI (LODR) Regulations, 2015 and in accordance with SEBI Circular dated 18-October-2019.

The statutory auditors, M/s. Eswara Rao & Co., Chartered Accountants (Firm Registration No. 000816S), resigned effective 28-October-2026. The company had appointed them on 10-October-2026 to fill a casual vacancy caused by the resignation of previous auditors M/s. Vasavi & Co., Chartered Accountants.

Key Details of Auditor Resignation:

  • Name of Auditor: M/s Eswara Rao & Co., Chartered Accountants
  • FRN: 000816S
  • Reason for Change: Resignation
  • Date of Cessation: 28-October-2026
  • Term of Appointment: Not applicable due to resignation
  • Detailed Reason: The statutory auditors resigned due to "unforeseen circumstances"

Auditor's Confirmation:

The auditors confirmed through their resignation letter dated 28-October-2026 that there were no other material reasons for resignation beyond the stated "unforeseen circumstances."

Additional Information from Auditor's Annexure:

The auditors provided detailed information in Annexure A dated 30-October-2026:

Auditor Details:

  • Address: Flat No. 403, Syamala Homes, 4/1, Syamala Nagar, Pattabhipuram, Guntur 522006

Association Details:

  • Appointment Date: 10-October-2026
  • Scheduled Term Expiry: Until conclusion of next Annual General Meeting (appointment by Board under Section 139(8)(i) of Companies Act, 2013)
  • Previous Reports: No audit or limited review reports issued prior to resignation

Detailed Reasons for Resignation:

Subsequent to their appointment on 10-October-2026, the auditors held a preliminary meeting with management and had begun receiving information for the limited review of financial results for the quarter ended 30-September-2026. However, before engagement work could commence, a medical emergency in the family required both partners responsible for the engagement to travel to Guntur at short notice.

The limited review report for Q2 FY2027 was due by 14-November-2026. As first-year auditors, they would have needed adequate time to understand the company's business, accounting systems, and internal controls. Given the circumstances, they determined they could not complete the limited review with required quality within the prescribed timeline, and no other partners in the firm had capacity to take up the engagement.

Additional Confirmations:

  • No concerns were raised with Audit Committee/Board of Directors prior to resignation
  • No issues with non-availability of information or non-cooperation by management
  • No management-imposed limitations or circumstances beyond management's control affecting information availability
  • No significant impact on financial statements due to lack of information
  • No alternative procedures were performed as no work had commenced
  • No prevalence of lack of information in previous financial statements

Regulatory Compliance:

The auditors confirmed they will file Form ADT-3 with the Registrar of Companies within 30 days of resignation as required under Section 140(2) of the Companies Act, 2013.

Financial Impact:

The disclosure does not quantify any financial impact of the auditor resignation. The company is now without statutory auditors and must appoint new auditors to complete the pending limited review for the quarter ended 30-September-2026, which has a submission deadline of 14-November-2026.